Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273-Reference-Cited by-同舟云学术

Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273

Published:2023-01 Issue:1 Volume:130 Page:67-73
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Ailsworth Samuel M.,Keshavarz Behnam,Richards Nathan E.,Workman Lisa J.,Murphy Deborah D.,Nelson Michael R.,Platts-Mills Thomas A.E.,Wilson Jeffrey M.

Funder

National Institutes of Health

NIAID

AAAAI

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference34 articles.

1. The role and uses of antibodies in COVID-19 infections: a living review;Scourfield;Oxf Open Immunol,2021

2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells and antibodies in coronavirus disease 2019 (COVID-19) protection: a prospective study;Molodtsov;Clin Infect Dis,2022

3. US Food and Drug Administration. Coronavirus (COVID-19) update: FDA expands eligibility for COVID-19 vaccine boosters. 2021. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters. Accessed July 15, 2022.

4. Effectiveness of mrna BNT162B2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study;Tartof;Lancet,2021

5. Covid-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study;Menni;Lancet Infect Dis,2022

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. Effects of the induction of humoral and cellular immunity by third vaccination for SARS-CoV-2;Journal of Infection and Chemotherapy;2024-10

3. Durability of SARS-CoV-2 IgG Antibodies: Insights from a Longitudinal Study, Puerto Rico;2024-08-03

4. Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2;Vaccine: X;2024-08

5. Mammalian Meat Allergy and IgE to Alpha-Gal in Central Virginia: Findings From a COVID-19 Vaccine and Patient Cohort;The Journal of Allergy and Clinical Immunology: In Practice;2024-06